BOZEN, Sud-Tirol, Italy, July 20, 2010 /PRNewswire/ — Health
Robotics today announced that it recently signed agreements to
grant exclusive CytoCare distribution rights in Spain and Portugal to world-leading IV Therapy
company Grifols S.A., and to install the first-ever Cancer Therapy
Robot in Spain at Vall d’Hebron
University Hospital in Barcelona
in November 2010.
“We are very excited to have been selected by Health Robotics as
their long-term exclusive CytoCare partner in Spain and Portugal, adding the Cancer Therapy
Robot in our core Iberian peninsula market to our prior i.v.STATION
distribution rights. CytoCare, the world’s first and only robotic
system designed for the safe and sterile preparation of
patient-specific hazardous IV Admixtures, represents an ideal
complement to our other market-leading Pharmacy Automation
products. Vall d’Hebron University Hospital has demonstrated a long
trajectory of innovation, utilizing new technologies to achieve
excellent peer-reviewed and published efficiency and medication
safety results, with prestigious awards such as Best European
Pharmacy Management, ESADE’s Management Innovation, and finally the
Best Health Care Ideas in 2009″, stated Xavier Guix, Vice President of Marketing
for Grifols’ Hospital System Division”.
“It is very exciting to expand our i.v.STATION relationship at
such a prestigious hospital as Vall d’Hebron University Hospital,
with its world-renowned cancer research program and the
well-documented scientific publications by Dr. Josep Monterde and his te
‘/>”/>
